The Chemours Company (CC) vs H. B. Fuller Company (FUL)
The Chemours Company and H. B. Fuller Company are both Specialty Chemicals companies. H. B. Fuller Company is the larger, with a market value of $2.6B against $2.1B — 1.2× the size. The Chemours Company has negative trailing earnings, so its P/E is not meaningful; H. B. Fuller Company trades at 14.7×. H. B. Fuller Company grew revenue faster over the last twelve months: −0.57% against −0.89%. H. B. Fuller Company has the higher net margin (5.29% vs −5.24%) and the higher return on invested capital (5.84% vs −2.22%). Both pay a dividend; The Chemours Company yields more (3.32% vs 1.11%). Across the 21 metrics below, H. B. Fuller Company leads on 15 and The Chemours Company on 6.
Valuation
Profitability
| Metric | CC | FUL | Specialty Chemicals median |
|---|---|---|---|
| Gross margin | 15.28% | 32.01% | 29.23% |
| Operating margin | (1.93%) | 10.76% | 3.63% |
| Net margin | (5.24%) | 5.29% | 2.89% |
| Free cash flow margin | 3.76% | 4.24% | 3.78% |
| Return on equity | (318.32%) | 9.38% | 3.62% |
| Return on assets | (4.15%) | 3.55% | 0.35% |
| Return on invested capital | (2.22%) | 5.84% | 2.75% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack